<?xml version="1.0" encoding="UTF-8"?>
<ref id="B1-pharmaceuticals-13-00313">
 <label>1.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alschuler</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Weil</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Horwitz</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Stamets</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Chiasson</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Crocker</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Maizes</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>Integrative considerations during the COVID-19 pandemic</article-title>
  <source>Explore</source>
  <year>2020</year>
  <comment>in press</comment>
  <pub-id pub-id-type="doi">10.1016/j.explore.2020.03.007</pub-id>
  <?supplied-pmid 32229082?>
  <pub-id pub-id-type="pmid">32229082</pub-id>
 </element-citation>
</ref>
